| Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells JY Hu, DL Zhang, XL Liu, XS Li, XQ Cheng, J Chen, HN Du, Y Liang Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (2), 414-427, 2017 | 79 | 2017 |
| Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis X Cheng, Y Hao, W Shu, M Zhao, C Zhao, Y Wu, X Peng, P Yao, D Xiao, ... Journal of Biological Chemistry 292 (22), 9022-9033, 2017 | 49 | 2017 |
| Sequence-dependent abnormal aggregation of human Tau fragment in an inducible cell model XL Liu, JY Hu, MY Hu, Y Zhang, ZY Hong, XQ Cheng, J Chen, DW Pang, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (8 …, 2015 | 12 | 2015 |
| HER2 and APC mutations promote altered crypt-villus morphology and marked hyperplasia in the intestinal epithelium E Murray, X Cheng, A Krishna, X Jin, TE Ohara, TS Stappenbeck, R Bose Cellular and Molecular Gastroenterology and Hepatology 12 (3), 1105-1120, 2021 | 6 | 2021 |
| Breast cancer mutations HER2V777L and PIK3CAH1047R activate the p21-CDK4/6–Cyclin D1 axis driving tumorigenesis and drug resistance X Cheng, Y Sun, M Highkin, N Vemalapally, X Jin, B Zhou, JL Prior, ... Cancer research 83 (17), 2839, 2023 | 2 | 2023 |
| Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance X Cheng, Y Sun, M Highkin, N Vemalapally, X Jin, B Zhou, JL Prior, ... Cancer research 83 (17), 2839-2857, 2023 | 2 | 2023 |
| Responses of photosynthetic traits of castor bean seedlings to cadmium and diethyl aminoethyl hexanoate Z Zhang, B Qian, X Cheng, C Liu, G Shi Journal of Nuclear Agricultural Sciences 25 (3), 602-608, 2011 | 2 | 2011 |
| Combining neratinib with trastuzumab deruxtecan to treat HER2; TP53 co-mutated breast cancers X Cheng, M Highkin, J Hsia, JL Prior, IS Hagemann, R Bose Cancer Research 84 (6_Supplement), 2828-2828, 2024 | | 2024 |
| Abstract 5778: Breast cancer mutations HER2V777L and PIK3CAH1047R activate the p21-CDK4/6 -Cyclin D1 axis driving tumorigenesis and drug resistance RB Cheng Xiaoqing, Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally ... American Association for Cancer Research 5778 (5778), 2023 | | 2023 |
Ian S. HagemannAssociate Professor, Dept. of Pathology and Immunology, Washington University in St. LouisVerified email at wustl.edu
